StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a research report released on Wednesday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance NYSE:BTX opened at $2.88 on Wednesday. The company’s fifty day moving average price is $3.42 and its 200-day moving average price is […]